TotalEnergies SE vs State Street SPDR S&P Biotech ETF — how do they compare? TotalEnergies SE trades at $86.89 (market cap $196.06B), while State Street SPDR S&P Biotech ETF trades at $159.04. The key difference: TotalEnergies SE pays a 4.82% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, TotalEnergies SE nearer its low. Which is the better fit depends on your goals.
| TTE | XBI | |
|---|---|---|
Market Cap | $196.06B | — |
Sector | Energy | Broad Market / Factor |
52-Week High | $93.60 | $164.28 |
52-Week Low | $57.39 | $86.92 |
Enterprise Value | $227.06B | — |
Dividend Yield | 4.82% | — |
Signals from Pluang's Aura AI — not financial advice
TotalEnergies SE (TTE) trades at $87.96, up 2.48% today, with a bullish technical signal and strong analyst support. Recent earnings show mixed quarterly beats, while the company expands in renewables and gas projects. Valuation ratios like P/E of 11.01 and P/S of 0.98 appear attractive relative to sector peers.
The outlook is positive given strategic acquisitions and gas field developments, but risks include revenue declines and legal challenges. With a consensus price target of $94.00 and 57.58% buy ratings, the stock offers upside potential amid energy transition opportunities.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →